BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases

  September 18, 2024

   · 

  3 min read
• Press Releases

  BioCardia Regains Full Compliance with Nasdaq Listing Requirements

  September 18, 2024

   · 

  3 min read
• Press Releases

  Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

  September 18, 2024

   · 

  3 min read
• Press Releases

  Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024

  September 18, 2024

   · 

  2 min read
• Press Releases

  Promino Nutritional Sciences Inc. Begins Preclinical Trial to Demonstrate Effectiveness of Promino™ Patented IP for Retention of Muscle Mass in Cancer Patients Undergoing Aggressive Chemotherapy Treatment

  September 18, 2024

   · 

  5 min read
• Press Releases

  New Alzheon Peer-Reviewed Scientific Publication Describes Study Design and Baseline Characteristics from APOLLOE4 Phase 3 Trial of Oral ALZ-801/Valiltramiprosate in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease

  September 18, 2024

   · 

  10 min read
• Press Releases

  Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

  September 18, 2024

   · 

  4 min read
• Press Releases

  FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)

  September 18, 2024

   · 

  19 min read
• Press Releases

  Marius Pharmaceuticals Partners with UK-Based Numan to Combat Testosterone Deficiency with KYZATREX® (Testosterone Undecanoate) CIII Capsules

  September 18, 2024

   · 

  9 min read
• Press Releases

  Specialist CRO Welcomes Dr Juan Gabriel Ovalles Bonilla as Medical Rheumatology Lead

  September 18, 2024

   · 

  1 min read